Favit-Van Pelt Antonella R. 4
4 · HELIUS MEDICAL TECHNOLOGIES, INC. · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Favit-Van Pelt Antonella R.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-07-02+17,500→ 17,500 totalExercise: $9.76Exp: 2035-07-01→ Class A Common Stock (17,500 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 50% of the options vested immediately upon grant, and the remaining options vest in a series of twelve (12) successive equal quarterly installments on the last day of each quarter starting on September 30, 2025, subject to the Reporting Person's continued service through each applicable vesting period.